These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30945122)

  • 1. Impact of rs12917 MGMT Polymorphism on [
    Kewitz-Hempel S; Kurch L; Cepelova M; Volkmer I; Sauerbrey A; Conrad E; Knirsch S; Pöpperl G; Steinbach D; Beer AJ; Kramm CM; Sahlmann CO; Erdlenbruch B; Reinbold WD; Odparlik A; Sabri O; Kluge R; Staege MS
    Mol Imaging Biol; 2019 Dec; 21(6):1182-1191. PubMed ID: 30945122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis.
    Kiczmer P; Prawdzic Seńkowska A; Strzelczyk JK; Szydło B; Biernacki K; Osadnik T; Krakowczyk Ł; Ostrowska Z
    Acta Biochim Pol; 2018; 65(1):87-92. PubMed ID: 29370316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Promoter Methylation and the rs12917 Polymorphism of MGMT with Formation of DNA Bulky Adducts and the Risk of Lung Cancer in Mexican Mestizo Population.
    Martínez-Ramírez OC; Pérez-Morales R; Castro-Hernández C; Gonsebatt ME; Casas-Ávila L; Valdés-Flores M; Petrosyan P; de León-Suárez VP; Rubio J
    DNA Cell Biol; 2019 Apr; 38(4):307-313. PubMed ID: 30785779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.
    Kurch L; Hasenclever D; Kluge R; Georgi T; Tchavdarova L; Golombeck M; Sabri O; Eggert A; Brenner W; Sykora KW; Bengel FM; Rossig C; Körholz D; Schäfers M; Feuchtinger T; Bartenstein P; Ammann RA; Krause T; Urban C; Aigner R; Gattenlöhner S; Klapper W; Mauz-Körholz C
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27539. PubMed ID: 30426671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients.
    McDonald KL; Rapkins RW; Olivier J; Zhao L; Nozue K; Lu D; Tiwari S; Kuroiwa-Trzmielina J; Brewer J; Wheeler HR; Hitchins MP
    Eur J Cancer; 2013 Jan; 49(2):360-8. PubMed ID: 22975219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers.
    Hill CE; Wickliffe JK; Guerin AT; Kinslow CJ; Wolfe KJ; Ammenheuser MM; Abdel-Rahman SZ
    Pharmacogenet Genomics; 2007 Sep; 17(9):743-53. PubMed ID: 17700363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of
    Sheng Z; Kang M; Wang H
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30232235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GSTM1null (deletion) and MGMT84 rs12917 (Phe/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes.
    Molina E; Pérez-Morales R; Rubio J; Petrosyan P; Cadena LH; Arlt VM; Phillips DH; Gonsebatt ME
    Mutat Res Genet Toxicol Environ Mutagen; 2013 Dec; 758(1-2):62-8. PubMed ID: 24084248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case.
    Altinoz MA; Elmaci I; Bolukbasi FH; Ekmekci CG; Yenmis G; Sari R; Sav A
    J Chemother; 2017 Aug; 29(4):238-244. PubMed ID: 28436299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
    Markova J; Kahraman D; Kobe C; Skopalova M; Mocikova H; Klaskova K; Dedeckova K; Eich HT; Böll B; Dietlein M; Kozak T
    Leuk Lymphoma; 2012 Jan; 53(1):64-70. PubMed ID: 21740300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping of the C>T allele of rs16906252, predictor of O16-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, in erosive atrophic lesions of oral lichen planus.
    Sánchez-Siles M; Aliaga-Sánchez A; Medina S; Adoamnei E; Fernández-Ruiz JA; Pelegrín-Hernández JP; Corno-Caparrós A; Rosa-Salazar V; Camacho-Alonso F
    Int J Dermatol; 2019 Sep; 58(9):1078-1082. PubMed ID: 31373397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.
    Rapkins RW; Wang F; Nguyen HN; Cloughesy TF; Lai A; Ha W; Nowak AK; Hitchins MP; McDonald KL
    Neuro Oncol; 2015 Dec; 17(12):1589-98. PubMed ID: 25910840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.
    Hu Y; Zhou M; Li K; Zhang K; Kong X; Zheng Y; Li J; Liu L
    Tumour Biol; 2014 Mar; 35(3):1715-25. PubMed ID: 24203816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
    Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
    Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism.
    Candiloro IL; Dobrovic A
    Cancer Prev Res (Phila); 2009 Oct; 2(10):862-7. PubMed ID: 19789298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.
    Kristensen LS; Nielsen HM; Hager H; Hansen LL
    Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma].
    Yang F; Shi JY; Xu L; Ren LJ; Zhang QH; Zhao WL; Shen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):622-5. PubMed ID: 19954624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
    Kluge R; Chavdarova L; Hoffmann M; Kobe C; Malkowski B; Montravers F; Kurch L; Georgi T; Dietlein M; Wallace WH; Karlen J; Fernández-Teijeiro A; Cepelova M; Wilson L; Bergstraesser E; Sabri O; Mauz-Körholz C; Körholz D; Hasenclever D
    PLoS One; 2016; 11(3):e0149072. PubMed ID: 26963909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.